"RecioMed is a multi-therapeutic phase 1-4 clinic located in Boynton Beach, Florida. We work with a variety of physicians to bring clinical trials to real world patients and provide reliable data for our pharmaceutical sponsors. RecioMed focuses on putting its patients first and aligning them with appropriate research opportunities that exist for them. Our staff places the highest importance on patient safety, which is then followed up with physician and staff support and training, as well as data integrity for our Pharma/biotech/CRO clients. RecioMed es una clínica multiterapéutica de fase 1-4."

During the past decade, RecioMed Clinical Research Network, Inc conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 1 clinical trials were completed. i.e. 12.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "RecioMed Clinical Research Network, Inc" #1 sponsor was "Pfizer" with 2 trials, followed by "Bodyport Inc." with 1 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored and "Guardant Health, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "RecioMed Clinical Research Network, Inc" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator and "Premier Research Group plc" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "RecioMed Clinical Research Network, Inc" are "COVID-19" (1 trials), "Colorectal Cancer" (1 trials), "Crohn's Disease" (1 trials), "Eosinophilic Esophagitis" (1 trials) and "Heart Failure" (1 trials). Many other conditions were trialed in "RecioMed Clinical Research Network, Inc" in a lesser frequency.

Most popular intervention types in "RecioMed Clinical Research Network, Inc" are "Drug" (6 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Etrasimod" (2 trials), "BMS-963272" (1 trials), "Bodyport Scale" (1 trials) and "Cobitolimod 250 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "RecioMed Clinical Research Network, Inc" are 8 trials for "All" genders.

Currently, there are NaN active trials in "RecioMed Clinical Research Network, Inc". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in RecioMed Clinical Research Network, Inc, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in RecioMed Clinical Research Network, Inc, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".